|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.11 EUR | -2.65% |
|
-6.78% | -33.33% |
| 2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Onxeo SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 1.44 million compared to EUR 4.06 million a year ago. Net loss was EUR 19.56 million compared to EUR 5.94 million a year ago.
Basic loss per share from continuing operations was EUR 0.18 compared to EUR 0.07 a year ago. Diluted loss per share from continuing operations was EUR 0.18 compared to EUR 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.33% | 18.09M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
VALERIO THERAPEUTICS 
